On 21 March 2013, the ABPI organised a half-day stakeholder workshop to explore definitions and guiding principles to enhance transparency in clinical trial reporting.
The idea for the workshop grew from discussions in which it was apparent that, while greater transparency was broadly welcomed, there was a lack of consensus on the degree of disclosure required to
The workshop therefore brought together a range of stakeholders, from industry, research-funding bodies, politics and other fields, to discuss the various aspects of clinical trial transparency and to establish a
framework and shared understanding that would facilitate future workshops addressing more specific issues.
This document explores what was discussed and the future challenges for all involved.